Loading chat...

SD HB1169

Bill

Status

Passed

3/9/2026

Primary Sponsor

Josephine Garcia

Click for details

Origin

House of Representatives

2026 Regular Session

AI Summary

  • Classifies medetomidine and any materials, compounds, mixtures, or preparations containing it as a Schedule III controlled substance under South Dakota law (chapter 34-20B)

  • Exempts veterinary use when dispensing, prescribing, or administering FDA-approved medetomidine drugs to animals

  • Permits manufacturing, distributing, or using medetomidine as an active pharmaceutical ingredient for approved animal drugs or those with investigational use exemptions

  • Allows licensed pharmacists and veterinarians to use medetomidine bulk chemicals for pharmaceutical compounding

  • Preserves any other uses approved or permissible under federal Food, Drug, and Cosmetic Act provisions (21 U.S.C. §§ 301-399i)

Legislative Description

Classify medetomidine as a Schedule III controlled substance and establish permissible uses.

Controlled Substances

Last Action

Signed by the Governor on March 09, 2026 H.J. 534

3/9/2026

Committee Referrals

Health and Human Services2/12/2026
Health and Human Services1/28/2026

Full Bill Text

No bill text available